Mesoblast (MESO) Cash & Current Investments (2014 - 2026)

Mesoblast has reported Cash & Current Investments for 11 years, with the latest figure at $130.0 million in Q4 2025.

• Quarterly Cash & Current Investments rose 241.78% year-over-year to $130.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $130.0 million (up 241.78% YoY) and the FY2025 annual result came in at $161.6 million, up 156.59% from the prior year.
• Cash & Current Investments eased to $130.0 million in Q4 2025 per MESO's latest filing, from $161.6 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $161.6 million in Q2 2025 and troughed at $38.0 million in Q4 2024.
• A 5-year average of $92.4 million and a median of $77.6 million in 2023 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2025: Cash & Current Investments sank 55.84% in 2022, then soared 241.78% in 2025.
• Over 5 years, Cash & Current Investments stood at $94.8 million in 2021, then retreated by 28.71% to $67.6 million in 2022, then climbed by 14.69% to $77.6 million in 2023, then tumbled by 50.96% to $38.0 million in 2024, then jumped by 241.78% to $130.0 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $130.0 million, $161.6 million, and $38.0 million for Q4 2025, Q2 2025, and Q4 2024 respectively.